Effect of retreatment with interferon alone or interferon plus ribavirin on hepatitis C virus quasispecies diversification in nonresponder patients with chronic hepatitis C

Journal of Virology

Volumn 73, Issue 9, 1999, Pages 7241-7247

  Gerotto, Martina ^a   Sullivan, Daniel G ^b   Polyak, Stephen J ^b   Chemello, Liliana ^a   Cavalletto, Luisa ^a   Pontisso, Patrizia ^a   Alberti, Alfredo ^a   Gretch, David R ^b  

^a UNIVERSITY OF PADOVA   (Italy)

^b UNIVERSITY OF WASHINGTON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; RIBAVIRIN;

ADULT; ARTICLE; CLINICAL ARTICLE; DRUG EFFICACY; DRUG MIXTURE; DRUG RESPONSE; FEMALE; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; MALE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SPECIES; VIRUS LOAD;

EID: 0032856708     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/jvi.73.9.7241-7247.1999     Document Type: Article

References (32)

1. Alter, M. J., H. S. Margolis, K. Krawczynski, F. N. Judson, A, Mares, W. J. Alexander, P. Y. Hu, J. K. Miller, M. A. Gerber, R. E. Sampliner, et al. 1992. The natural history of community-acquired hepatitis C in the United States. The Sentinel Counties Chronic non-A, non-B Hepatitis Study Team. N. Engl. J. Med. 327:1899-1905.
2. Brown, J. L. 1998. Efficacy of combined interferon and ribavirin for treatment of hepatitis C. Lancet 351:78-80.
3. Bukh, J., R. Miller, and R. Purcell. 1995. Genetic heterogeneity of hepatitis C virus: quasispecies and genotypes. Semin. Liver Dis. 15:41-63.
4. Chemello, L., L. Cavalletto, E. Bernardinello, M. Guido, P. Pontisso, and A. Alberti. 1995. The effect of interferon alpha and ribavirin combination therapy in naive patients with chronic hepatitis C. J. Hepatol. 23:8-12.
5. Chayama, K., A. Tsubota, M. Kabayashi, K. Okamoto, M. Hashimoto, Y. Miyano, H. Koike, M. Kobayashi, I. Koida, S. Saitoh, Y. Suzuki, N. Murashima, K. Ikeda, and H. Kumada. 1997. Pretreatment virus load and multiple amino acid substitutions in the interferon sensitivity determining region predict the outcome of interferon treatment in patients with chronic genotype 1b hepatitis C virus infection. Hepatology 25:745-749.
6. Chomczynski, P., and N. Sacchi. 1987. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem. 162:156-159.
7. Choo, Q. L., G. Kuo, A. J. Weiner, L. R. Overby, D. W. Bradley, and M. Houghton. 1989. Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome. Science 244:359-362.
8. Davis, G. L., R. Esteban-Mur, V. Rustgi, J. Hoefs, S. C. Gordon, C. Trepo, M. L. Shiffman, S. Zeuzem, A. Craxì, M.-H. Ling, and J. Alvrecht. 1998. Interferon alpha-2b alone or in combination with ribavirin for the treatment of relapse of chronic hepatitis C. N. Engl. J. Med. 339:1493-1499.
9. Enamoto, N., I. Sakuma, Y. Asahina, M. Kurosaki, T. Murakami, C. Yamamoto, Y. Ogura, N. Izumi, F. Marumo, and C. Sato. 1996. Mutations in the nonstructural protein 5A gene and response to interferon in patients with chronic hepatitis C virus 1b infection. N. Engl. J. Med. 334:77-81.
10. Farci, P., H. J. Alter, D. C. Wong, R. H. Miller, S. Govindarajan, R. Engle, M. Shapiro, and R. H. Purcell. 1994. Prevention of hepatitis C virus infection in chimpanzees after antibody-mediated in vitro neutralization. Proc. Natl. Acad. Sci. USA 91:7792-7796.
11. Fukuma, T., N. Enamoto, F. Marumo, and C. Sato. 1998. Mutations in the interferon-sensitivity determining region of hepatitis C virus and transcriptional activity of the nonstructural region 5A protein. Hepatology 28:1147-1153.
12. Gonzales-Peralta, R. P., W. Z. Lui, G. L. Davis, K. P. Qian, and J. Y. N. Lau. 1997. Modulation of hepatitis C virus quasispecies heterogeneity by interferon alpha and ribavirin therapy. J. Viral Hepatol. 4:99-106.
13. Gonzalez-Peralta, R. P., K. Qian, J. Y. She, G. L. Davis. T. Ohno, M. Mizokami, and J. Y. N. Lau. 1996. Clinical implications of viral quasispecies heterogeneity in chronic hepatitis C. J. Med. Virol. 49:242-247.
14. Gretch, D. R., C. dela Rosa, R. L. Carithers, R. A. Willson, B. Williams, and L. Corey. 1995. Assessment of hepatitis C viremia using molecular amplification technologies: correlations and clinical implications. Ann. Intern. Med. 123:321-329.
15. Gretch, D. R., S. J. Polyak, J. J. Wilson, R. L. Carithers, J. D. Perkins, and L. Corey. 1996. Tracking hepatitis C virus quasispecies major and minor variants in symptomatic and asymptomatic liver transplant recipients. J. Virol. 70:7622-7631.
16. Gretch, D. R., and S. J. Polyak. 1997. The quasispecies nature of hepatitis C virus: research methods and biological implications, p. 57-69. In Groupe Français d'Etudes Moleculaires des Hepatites (GEMHEP) (ed.), Proceedings of the Hepatitis C virus GEMHEP Conference. John Libbey Eurotext, Paris, France.
17. Hoofnagle, J. H., and A. M. Di Bisceglie. 1997. The treatment of chronic viral hepatitis. N. Engl. J. Med. 336:347-356.
18. Holland, J. J., J. C. De La Torre, and D. A. Steinhauer. 1992. RNA virus populations as quasispecies. Curr. Top. Microbiol. Immunol. 176:1-20.
19. Kanazawa, Y., N. Hayashi, E. Mita, T. Li, H. Hagiwara, A. Kasahara, H. Fusamoto, and T. Kamada. 1994. Influence of viral quasispecies on effectiveness of interferon therapy in chronic hepatitis C patients. Hepatology 20:1121-1130.
20. Kato, N., H. Sekiya, Y. Ootsuyama, T. Nakazawa, M. Hijikata, S. Ohkoshi, and K. Shimotohno. 1993. Humoral immune response to hypervariable region 1 of the putative envelope glycoprotein (gp70) of hepatitis C virus. J. Virol. 67:3923-3930.
21. Martell, M., J. I. Esteban, J. Quer, J. Genesca, A. Weiner, R. Esteban, J. Guardia, and J. Gomez. 1992. Hepatitis C virus (HCV) circulates as a population of different but closely related genomes: quasispecies nature of HCV genome distribution. J. Virol. 66:3225-3229.
22. Martin, J., S. Navas, J. A. Quiroga, M. Pardo, and Y. Carreno. 1998. Effects of the ribavirin-interferon α combination on cultured peripheral blood mononuclear cells from chronic hepatitis C patients. Cytokine 10:635-644.
23. Moribe, T., N. Hayashi, Y. Kanazawa, E. Mita, H. Fusamoto, M. Negi, T. Kaneshige, H. Igimi, T. Kamada, and K. Uchida. 1995. Hepatitis C viral complexity detected by single-strand conformation polymorphism and response to interferon therapy. Gastroenterology 108:789-795.
24. Okada, S., Y. Akahane, H. Suzuki, H. Okamoto, and S. Mishiro. 1992. The degree of variability in the amino terminal region of the E2/NS1 protein of hepatitis C virus correlates with responsiveness to interferon therapy in viremic patients. Hepatology 16:619-624.
25. Polyak, S., G. Faulkner, R. Carithers, Jr., L. Corey, and D. Gretch. 1997. Assessment of hepatitis C virus quasispecies heterogeneity by gel shift analysis: correlation with response to interferon therapy. J. Infect. Dis. 175:1101-1107.
26. Polyak, S. J., S. McArdle, S.-L. Liu, D. G. Sullivan, M. Chung, W. T. Hofgärtner, R. L. Carithers, B. J. McMahon, J. I. Mullins, L. Corey, and D. R. Gretch. 1998. Evolution of hepatitis C virus quasispecies in the hypervariable region 1 and the interferon sensitivity determining region during interferon therapy and natural infection. J. Virol. 72:4288-4296.
27. Schalm, S. W., B. E. Hansen, L. Chemello, A. Bellobuono, J. T. Brouwer, and O. Weiland. 1997. Ribavirin enhances the efficacy but not the adverse effects of interferon in chronic hepatitis C: meta-analysis of individual patient data from European centers. J. Hepatol. 26:961-966.
28. Squadritto, G., F. Leone, M. Sartori, B. Nalpas, P. Berthelot, G. Raimondo, S. Pol, and C. Brechot. 1997. Mutations in the nonstructural 5A region of hepatitis C virus and response of chronic hepatitis C to interferon alpha. Gastroenterology 113:567-572.
29. Sullivan, D. G., J. J. Wilson, R. L. Carithers, J. D. Perkins, and D. R. Gretch. 1998. Multigene tracking of hepatitis C virus quasispecies after liver transplantation: correlation of genetic diversification in the envelope region with asymptomatic or mild disease patterns. J. Virol. 72:10036-10043.
30. Weiner, A. J., H. M. Geysen, C. Christopherson, J. E. Hall, T. J. Mason, G. Saracco, F. Bonino, K. Crawford, C. D. Marion, K. A. Crawford, M. Brunetto, P. J. Barr, T. Miyamura, J. McHutchinson, and M. Houghton. 1992. Evidence for immune selection of hepatitis C virus (HCV) putative envelope glycoprotein variants: potential role in chronic HCV infections. Proc. Natl. Acad. Sci. USA 89:3468-3472.
31. Wilson, J. J., S. J. Polyak, T. D. Day, and D. R. Gretch. 1995. Characterization of simple and complex hepatitis C virus quasispecies by heteroduplex gel shift analysis: correlation with nucleotide sequencing. J. Gen. Virol. 76:1763-1771.
32. Zeuzem, S., J. H. Lee, and W. K. Roth. 1997. Mutations in the nonstructural 5A gene of European hepatitis C virus isolates and response to interferon alpha. Hepatology 25:740-744.